{"entity":{"type":"insider","cik":"0001323495","url":"/insider/0001323495","json_url":"/insider/0001323495.json","name":"Yocum Richard C","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":1,"first":"2007-03-23","last":"2007-03-23","span_basis":"filed_date"},"name_variants":[{"name":"Yocum Richard C","source":"filing","n_filings":1,"first_seen":"2007-03-23","last_seen":"2007-03-23"}],"transactions":[{"id":8452422,"accession":"0001181431-07-021088","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001181431-07-021088","line_url":"/filing/0001181431-07-021088","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HTI","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001323495","owner_name":"Yocum Richard C","owner_display_name":"Yocum Richard C","owner_url":"/insider/0001323495","role":"Officer (VP Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29858.0,"shares_display":"29,858","price_per_share":8.488721950566012,"price_display":"8.49","price_state":"stated","total_value":253456.26,"total_display":"253,456.26","total_whole":"253,456","shares_owned_after":69075.0,"shares_owned_after_display":"69,075","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-03-22","filed_date":"2007-03-23","scope":"insider","n_lines":8}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001159036","name":"HALOZYME THERAPEUTICS INC","url":"/issuer/0001159036","role":"Officer (VP Clinical Development)","n_filings":1,"first_seen":"2007-03-23","last_seen":"2007-03-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001323495","retrieved_at":"2026-08-23T22:12:59+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}